Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
This piece identifies funds with the highest management charges in the Dividend Aristocrats group and explains potential impact on performance.
26,423 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
ZIM shares hover near $27.54, well under Hapag-Lloyd’s $35 cash proposal. The discount reflects regulatory risk aroun...
Circle helped popularize stablecoins with USDC, but looming regulatory moves could reshape its growth path. This arti...
Bitcoin surged beyond the $82,000 level this week, reviving bullish chatter while alerting analysts to rising risk as...
Ambiq Micro is navigating a crowded IoT market with its ultra-low power chips. This article breaks down what to expec...
A Chicago federal jury has ordered Boeing to pay $49.5 million to Samya Stumo's family, ending a high-profile liabili...
Investors confront a familiar fork: cash out a top-performing rental to ease debt on another, or hold for long-term g...
The NHL and CFTC have agreed to study licensed, crypto-backed sports prediction markets under a new memorandum of und...
SpaceX is pursuing a bold, trillion-dollar plan to become the backbone of global connectivity. As markets watch, inve...
When personal life meets the public eye, money isn’t far behind. This article explores the financial fallout of high-...
Behind the laughs in a famous action comedy lies a practical finance lesson: when two people speak different financia...
Ferrari is betting big on an electric future. This daring move could unlock new investor opportunities even as it tes...